Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totaling 21,299 shares, a growth of 50.0% from the July 15th total of 14,197 shares. Currently, 0.3% of the company’s stock are sold short. Based on an average daily trading volume, of 36,032 shares, the short-interest ratio is currently 0.6 days.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, May 26th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Insider Activity

In related news, Director Ting-Chuan Lee sold 109,988 shares of the firm’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $1.90, for a total transaction of $208,977.20. Following the sale, the director directly owned 807,417 shares in the company, valued at $1,534,092.30. This trade represents a 11.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, major shareholder Carbon Nano Technology Taiwan sold 41,000 shares of the stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $2.36, for a total value of $96,760.00. Following the transaction, the insider owned 948,925 shares of the company’s stock, valued at approximately $2,239,463. This trade represents a 4.14% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders purchased 7,500 shares of company stock worth $15,435 and sold 179,788 shares worth $359,247. Corporate insiders own 9.79% of the company’s stock.

Institutional Investors Weigh In On Ainos

A number of hedge funds and other institutional investors have recently modified their holdings of the company. DRW Securities LLC grew its stake in shares of Ainos by 272.6% in the fourth quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock valued at $109,000 after acquiring an additional 48,439 shares in the last quarter. Two Sigma Investments LP acquired a new stake in Ainos in the 3rd quarter worth about $80,000. Mariner LLC bought a new stake in Ainos in the 4th quarter valued at about $37,000. Finally, Renaissance Technologies LLC grew its position in shares of Ainos by 13.1% during the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after purchasing an additional 7,700 shares in the last quarter.

Ainos Price Performance

Ainos stock traded up $0.06 during trading hours on Wednesday, hitting $1.46. The company had a trading volume of 9,035 shares, compared to its average volume of 424,405. The firm has a market cap of $10.74 million, a PE ratio of -0.58 and a beta of 2.46. Ainos has a one year low of $1.26 and a one year high of $4.44. The firm has a 50-day moving average of $1.68 and a 200 day moving average of $1.71.

Ainos (NASDAQ:AIMD) last announced its earnings results on Monday, August 3rd. The company reported ($0.62) earnings per share for the quarter. The firm had revenue of $0.15 million for the quarter. Ainos had a negative return on equity of 217.50% and a negative net margin of 11,912.10%.

Ainos Company Profile

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.